Summary
The possible influence of C-peptide administration on renal function and whole body glucose utilization was examined in 11 patients (Group 1) with Type 1 (insulin-dependent) diabetes mellitus. They were given an i. v. insulin infusion during the night before the study and were euglycaemic at the time of examination. The glomerular filtration rate and effective renal plasma flow were measured by clearance techniques using constant-rate infusions of inulin and sodium para-aminohippurate. After baseline measurements C-peptide was infused during two periods of 60 min at rates of 5 and 30 pmol·kg−1·min−1. In a control study 0.9% NaCl was infused during two 60 min periods in ten Type 1 diabetic patients (Group 2), Glomerular filtration rate decreased by 7%(p<0.001), effective renal plasma flow increased by 3%, (p<0.05) and whole-body glucose utilization rose by approximately 25%(p<0.05) above basal during low-dose C-peptide infusion. Group 2 showed an unaltered glomerular filtration rate, effective renal plasma flow and glucose utilization during 60 min of NaCl infusion. The differences between Group 1 and Group 2 in glomerular filtration rate and glucose utilization were statistically significant. It is concluded that short-term administration of C-peptide in physiological amounts to patients with Type 1 diabetes may reduce the glomerular filtration rate and increase whole-body glucose utilization. The results suggest the possibility that short-term C-peptide administration may exert a regulatory influence on renal function and stimulate glucose utilization in Type 1 diabetic patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Steiner DF (1978) On the role of the proinsulin C-peptide. Diabetes 27 [Suppl 1]: 145–148
Heding LG (1978) Insulin, C-peptide, and proinsulin in non-diabetics and insulin-treated diabetics. Diabetes 27 [Suppl 1]: 178–183
Blix PM, Boddie-Willis C, Landau RL, Rochman H, Rubenstein AH (1982) Urinary C-peptide: an indicator of beta-cell secretion under different metabolic conditions. J Clin Endocrinol Metab 54: 547–580
Stalder G, Schmid R (1959) Severe functional disorders of glomerular capillaries and renal hemodynamics in treated diabetes mellitus during childhood. Ann Paediatr 193: 129–138
Mogensen CE, Andersen MJF (1973) Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 22: 706–712
Mogensen CE (1972) Glomerular filtration rate and renal plasma flow in long-term juvenile diabetics without proteinuria. Br Med J 4: 257–259
Mogensen CE, Christensen CK, Beck Nielsen H, Vittinghus E (1983) Early changes in kidney function, blood pressure and the stages in diabetic nephropathy. In: Keen H, Legrain M (eds) Prevention and treatment of diabetic nephropathy. MTP press, Lancaster, pp 57–83
Mogensen CE, Andersen MJF (1974) Increased kidney size and glomerular filtration rate in untreated juvenile diabetes. Normalisation by insulin treatment. Diabetologia 11: 221–224
Sandahl-Christiansen J, Gammelgaard J, Tronier B, Svendsen PA, Parving HH (1982) Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int 21: 683–688
Sandahl-Christiansen J, Frandsen M, Parving HH (1981) The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus. Diabetologia 20: 199–204
Østerby R, Gundersen HJG (1975) Glomerular size and structure in diabetes mellitus. I. Early abnormalities. Diabetologia 11: 225–229
Gundersen HJG, Østerby R (1977) Glomerular size and structure in diabetes mellitus. II. Late abnormalities. Diabetologia 13: 43–48
Friedman EA, Sheih S-D, Hirsch SR, Boshell BR (1981) No supranormal glomerular filtration (GFR) in type II (non-insulin-dependent) diabetes. Am Soc Nephrol 14: 102A (Abstract)
Schmitz A, Gundersen HJG, Østerby R (1988) Glomerular morphology by light microscopy in non-insulin-dependent diabetes mellitus. Diabetes 37: 38–43
Haycock GB, Schwartz GJ, Wisotsky DH (1978) Geometric method for measuring body surface area: a height-weight formula validated in infants, children and adults. J Paediatr 93: 62–66
Heding LG (1975) Radioimmunological determination of human C-peptide in serum. Diabetologia 11: 541–548
Sjöberg S, Gunnarsson R, Gjötterberg M, Lefvert A-K, Person A, Östman J (1987) Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term insulin-dependent diabetes. Diabetologia 30: 208–213
Hilger HH, Klumper JD, Ullrich KJ (1958) Wasserrückresorption und Ionentransport durch die Sammelrohrzellen der Säugetierniere. Pflugers Arch 267: 218–237
Smith HW, Finkelstein N, Aliminosa L, Crawford B, Graber M (1945) The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest 24: 388–404
DeFronzo RA, Tobin DT, Reubin R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-E223
Polonsky KS, Licinio-Paixao J, Given BD et al. (1986) Use of biosynthetic human C-peptide in the measurements of insulin secretion in normal volunteers and type 1 diabetic patients. J Clin Invest 77: 98–105
Hagen C, Faber OK, Binder C, Alberti KGMM (1977) Lack of metabolic effects of C-peptide in normal and juvenile diabetic patients. Acta Endocrinol 85 [Suppl 209]: 29A (Abstract)
Wallberg-Henriksson H, Andréasson K, Galuska D et al. (1989) C-peptide stimulates glucose transport in incubated normal muscle but not in muscles from type II diabetic patients. Diabetologia 32: 555A (Abstract)
Zierath JR, Thörne A, Johansson B-L, Wallberg-Henriksson H (1990) C-peptide stimulates glucose transport in type 1 diabetic skeletal muscle. Diabetes 39: 564A (Abstract)
Hoogwerf BJ, Bantle JP, Gaenslen HE et al. (1986) Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjects. Metabolism 35: 122–125
Wojcikowski Cz, Maier V, Dominiak K, Pfeiffer EF (1985) Effects of synthetic rat C-peptide in normal and diabetic rats. Diabetologia 25: 288–290
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Johansson, B.L., Sjöberg, S. & Wahren, J. The influence of human C-peptide on renal function and glucose utilization in Type 1 (insulin-dependent) diabetic patients. Diabetologia 35, 121–128 (1992). https://doi.org/10.1007/BF00402543
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00402543